{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:35Z","timestamp":1789609115044,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1415,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1365-2133.2011.10585.x","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T22:52:25Z","timestamp":1315867945000},"page":"154-160","source":"Crossref","is-referenced-by-count":73,"title":["Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine\/mycophenolate mofetil: a pilot study of 23 patients"],"prefix":"10.1093","volume":"166","author":[{"given":"M.","family":"Kasperkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Shimanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB1|cit1","first-page":"459","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Stanley","year":"2008"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08916930600971414","article-title":"Pemphigus in the XXI century: new life to an old story","volume":"39","author":"Grando","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB3|cit3","first-page":"399","article-title":"Diagnosis and treatment of autoimmune blistering skin diseases","volume":"108","author":"Schmidt","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.2007.08358.x","article-title":"Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins","volume":"158","author":"Shimanovich","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","article-title":"Immunoadsorption in dermatology","volume":"302","author":"Schmidt","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1365-2133.2003.05302.x","article-title":"Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus","volume":"148","author":"Schmidt","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/1523-1747.ep12277362","article-title":"Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB\/c mice by passive transfer","volume":"85","author":"Roscoe","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archderm.134.6.706","article-title":"Immunoapheresis in paraneoplastic pemphigus","volume":"134","author":"Schoen","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2133.2003.05513.x","article-title":"Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with tryptophan-linked polyvinylalcohol adsorber","volume":"149","author":"L\u00fcftl","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1074\/jbc.M309000200","article-title":"Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes","volume":"279","author":"Nguyen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaad.2010.07.032","article-title":"Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients","volume":"65","author":"Kasperkiewicz","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2133.2011.10411.x","article-title":"Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients","volume":"165","author":"Kim","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/17469872.3.3.259","article-title":"CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab","volume":"3","author":"Schmidt","year":"2008","journal-title":"Expert Rev Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"Single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10585.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12016-007-8021-6","article-title":"Rituximab in treatment-resistant autoimmune blistering skin disorders","volume":"34","author":"Schmidt","year":"2008","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10585.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10585.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:53:18Z","timestamp":1676382798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/1\/154\/6613773"}},"subtitle":["Novel treatment protocol for severe pemphigus"],"short-title":[],"issued":{"date-parts":[[2011,10,17]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10585.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,17]]}}}